APPLICATION
ANDA077019
TYPE
ANDA
ORIGINAL APPROVAL
2004-11-23
LATEST ACTION
2020-11-10
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued
Products
CILOSTAZOLDiscontinued
CILOSTAZOL 50MG · TABLET · ORAL
CILOSTAZOLDiscontinued
CILOSTAZOL 100MG · TABLET · ORAL
Approval history
2020-11-10Labeling · Supplement 3 · standardAP
2009-06-03Labeling · Supplement 1AP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.